Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex.
Antimitochondrial antibodies (AMA) recognizing the acetyltransferase (E2) of the pyruvate dehydrogenase (PDH) complex have been previously well-documented and the immunodominant epitope mapped. In this study, we demonstrate that sera from patients with primary biliary cirrhosis (PBC) react with another lipoic acid containing acyltransferase enzyme, namely the E2 of the branched chain alpha-ketoacid dehydrogenase (BCKD) complex. Indeed, 85/120 (71%) sera from patients with PBC reacted with BCKD-E2 by immunoblotting against purified BCKD complex. In contrast, sera from patients with chronic active hepatitis or progressive sclerosing cholangitis as well as sera from healthy volunteers did not react with any component enzymes of the BCKD complex. More importantly, BCKD enzyme activity was inhibited after incubation of the BCKD complex with either PBC sera against BCKD-E2 or with affinity purified antisera to BCKD-E2. Enzyme activity was unaltered by control sera or with PBC sera that reacted with PDH-E2 but not BCKD-E2. Furthermore, immunoblots of purified mitochondria probed with PBC sera absorbed with BCKD-E2 demonstrated that BCKD-E2 and PDH-E2 are each recognized by distinct AMA populations which do not cross-react. In addition, affinity purified PBC sera against BCKD-E2 did not react with PDH-E2 nor inhibit PDH enzyme activity, thus providing further evidence that BCKD-E2 and PDH-E2 are recognized by separate AMA. These data further suggest that the BCKD-E2 epitope recognized by AMA contains, or is close to, a functional domain of this enzyme. The availability of cDNA clones encoding BCKD-E2 and PDH-E2 will allow the study of how key metabolic enzymes may be involved in the immunology and pathology of PBC.
Fregeau
D R
DR
Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis 95616.
Davis
P A
PA
Danner
D J
DJ
Ansari
A
A
Coppel
R L
RL
Dickson
E R
ER
Gershwin
M E
ME
D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); D000042:Absorption; D000123:Acetyltransferases / Q000276:immunology*; D001323:Autoantibodies / Q000502:physiology*; D003101:Collodion; D051047:Dihydrolipoyllysine-Residue Acetyltransferase; D004797:Enzyme-Linked Immunosorbent Assay; D004800:Enzymes, Immobilized; D006801:Humans; D007106:Immune Sera / Q000302:isolation & purification; D015151:Immunoblotting; D007658:Ketone Oxidoreductases / Q000037:antagonists & inhibitors* / Q000302:isolation & purification; D008105:Liver Cirrhosis, Biliary / Q000276:immunology*; D008930:Mitochondria, Liver / Q000276:immunology*; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors* / Q000302:isolation & purification; D011768:Pyruvate Dehydrogenase Complex
D001323:Autoantibodies; D004800:Enzymes, Immobilized; D007106:Immune Sera; D009097:Multienzyme Complexes; D011768:Pyruvate Dehydrogenase Complex; D003101:Collodion; D007658:Ketone Oxidoreductases; D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); D000123:Acetyltransferases; D051047:Dihydrolipoyllysine-Residue Acetyltransferase